CHP
IART icon

Cable Hill Partners’s Integra LifeSciences IART Stock Holding History

Cable Hill Partners’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-229
Closed -$12K – 994
2017
Q2 		$12K Sell
229
-1
-0.4% -$48 0.01% 358
2017
Q1 		$10K Buy
230
+94
+69% +$4.02K 0.01% 397
2016
Q4 		$6K Buy
136
+100
+278% +$4.07K ﹤0.01% 513
2016
Q3 		$1K Buy
+36
New +$1.51K ﹤0.01% 803

Other funds holding IART

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Cable Hill Partners's IART Position: Q3 2017 in Review

Cable Hill Partners sold out of Integra LifeSciences (IART) in Q3 2017, closing a stake of 229 shares — an estimated $12K sold.

Cable Hill Partners first reported a position in IART in Q3 2016 and held it in 4 quarters. The position peaked at $12K in Q2 2017. 213 funds tracked by Wall St. Rank hold IART as of Q3 2017.

  • Cable Hill Partners reported no remaining Integra LifeSciences position as of Q3 2017 after selling out during the quarter.
  • Cable Hill Partners sold 229 Integra LifeSciences shares in Q3 2017, an estimated $12K.
  • Cable Hill Partners first reported a position in Integra LifeSciences in Q3 2016 and held it in 4 quarters.
  • Cable Hill Partners's Integra LifeSciences position peaked at $12K in Q2 2017.
  • 213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2017.

Based on Cable Hill Partners's 13F filing for Q3 2017, filed 27 Oct 2017.